Employees with such chronic diseases as asthma, diabetes and high blood pressure spend fewer days out of the office when they are adherent to their medications, according to new research conducted by CVS Caremark and Truven Health Analytics (previously the healthcare business of Thomson Reuters).
Changes in healthcare consumption, advances in technology and support from pharmacists are among seven new trends that could affect programs designed to improve medication adherence, according to a new study by McKesson.
While most of the attention to the Prescription Drug User Fee Act reauthorization focused on what it would mean for the generic drug industry, one other aspect of the law recently drew applause from a group that advocates on behalf of the blind.
Sens. Bob Casey, D.-Pa., and Lisa Murkowski, R-Alaska, on Wednesday introduced bipartisan legislation to prevent the abuse of cough syrup to get high by restricting the sale of products containing dextromethorphan to adults older than 18 years of age.
As states grapple with tight budgets, rising Medicaid costs and the anticipated expansion of Medicaid following the Supreme Court's decision to uphold the Patient Protection and Affordable Care Act, policymakers should consider how community pharmacists can help reduce expenses. In addition, new evidence offers a fresh reminder of the perils of managed care in Medicaid and the need for proper oversight of managed care entities.
Owning and operating a community pharmacy has never been the easiest way to prosper in the healthcare field. But in the face of unrelenting reimbursement challenges, big-chain competition and the pressures imposed by powerful pharmacy benefit managers that dictate take-it-or-leave-it contracts covering the majority of patients and prescriptions, it’s a safe bet that the vast majority of independent and small-chain pharmacy owner/operators wouldn’t trade places with any other health professional.
It’s been cited as one of the biggest health crises facing the United States and, if solved, the equivalent dollar value of a blockbuster drug. According to the latest statistics from pharmacy benefit manager Express Scripts, poor medication adherence costs the country $317 billion per year, an upgrade from the $290 billion calculated in a study released in 2009 by the New England Healthcare Institute.
Currently there are two overarching legislative issues that either threaten to place greater restrictions on certain over-the-counter medicines or fail to restore access to an OTC benefit that once played a significant role in helping develop interest in the flexible spending account plans available today.